These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11280768)

  • 1. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23.
    Tseng YH; Vicent D; Zhu J; Niu Y; Adeyinka A; Moyers JS; Watson PH; Kahn CR
    Cancer Res; 2001 Mar; 61(5):2071-9. PubMed ID: 11280768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH; Liu HS; Chan SH
    Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
    J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
    Leone A; Flatow U; VanHoutte K; Steeg PS
    Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
    Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
    Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DR-nm23 expression affects neuroblastoma cell differentiation, integrin expression, and adhesion characteristics.
    Amendola R; Martinez R; Negroni A; Venturelli D; Tanno B; Calabretta B; Raschellà G
    Med Pediatr Oncol; 2001 Jan; 36(1):93-6. PubMed ID: 11464913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nm23 and tumour metastasis: basic and translational advances.
    Freije JM; MacDonald NJ; Steeg PS
    Biochem Soc Symp; 1998; 63():261-71. PubMed ID: 9513729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sensitivity to cisplatin by nm23-transfected tumor cell lines.
    Ferguson AW; Flatow U; MacDonald NJ; Larminat F; Bohr VA; Steeg PS
    Cancer Res; 1996 Jul; 56(13):2931-5. PubMed ID: 8674043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of retinoic acid on metastasis and its related proteins in gastric cancer cells in vivo and in vitro.
    Wu Q; Chen YQ; Chen ZM; Chen F; Su WJ
    Acta Pharmacol Sin; 2002 Sep; 23(9):835-41. PubMed ID: 12230954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.
    Pan Q; Bao LW; Kleer CG; Sabel MS; Griffith KA; Teknos TN; Merajver SD
    Cancer Res; 2005 Sep; 65(18):8366-71. PubMed ID: 16166314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Ouatas T; Halverson D; Steeg PS
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
    Liu H; Mao H; Fu X
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
    Baba H; Urano T; Okada K; Furukawa K; Nakayama E; Tanaka H; Iwasaki K; Shiku H
    Cancer Res; 1995 May; 55(9):1977-81. PubMed ID: 7728768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
    Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
    Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
    Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
    Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1.
    Otsuki Y; Tanaka M; Yoshii S; Kawazoe N; Nakaya K; Sugimura H
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4385-90. PubMed ID: 11274357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
    Liu F; Zhang Y; Zhang XY; Chen HL
    J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells.
    Kudoh M; Knee DA; Takayama S; Reed JC
    Cancer Res; 2002 Mar; 62(6):1904-9. PubMed ID: 11912172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.